Clinical trials
Trials in Cuba
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 23 |
| 2010 | 6 |
| 2011 | 2 |
| 2014 | 4 |
| 2015 | 7 |
| 2017 | 2 |
| 2018 | 9 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
| Unknown status | 8 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Catalysis SL | 39 |
| Hoffmann-La Roche | 4 |
| Mediterranea Medica S. L. | 4 |
| International Atomic Energy Agency | 3 |
| International Center for Neurological Restoration, Cuba | 3 |
| ARDEC Academy | 2 |
| University of Heidelberg Medical Center | 2 |
| Eurofarma Laboratorios S.A. | 1 |
| Fresenius Medical Care Deutschland GmbH | 1 |
| Fundacion Clinica Valle del Lili | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 4 |
| Digestive System Diseases | 3 |
| Digestive System Neoplasms | 3 |
| Insulin Resistance | 3 |
| Leiomyoma | 3 |
| Parkinson Disease | 3 |
| Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Dengue | 2 |
| Diabetes Mellitus | 2 |
Trials
Showing 76 to 67 of 67. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.